Shef Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.25 M
- Paid Up Capital ₹ 1.25 M
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.50 M
About Shef Biotech
Shef Biotech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 February 2006 and has a history of 18 years and 11 months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 M and a paid-up capital of Rs 1.25 M.
The company has closed loans amounting to ₹7.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anju Jhalani, Saksham Jhalani, Shefali Jhalani, and Two other members serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232RJ2006PTC022144
-
Company No.
022144
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Shef Biotech?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saksham Jhalani
|
Director | 03-Jun-2019 | Current |
|
Anju Jhalani
|
Director | 24-Feb-2006 | Current |
|
Shefali Jhalani
|
Director | 27-Jun-2018 | Current |
|
Lalita Jhalani
|
Director | 22-Jun-2007 | Current |
|
Bhunesh Jhalani
|
Director | 24-Feb-2006 | Current |
Financial Performance of Shef Biotech.
Shef Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shef Biotech?
In 2017, Shef Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Saksham Buildcon Private LimitedAnju Jhalani and Bhunesh Jhalani are mutual person
-
Maxis Bio Science Private Limited
Bhunesh Jhalani is a mutual person
Charges (Loans)
₹0
₹7.50 M
Charges Breakdown by Lending Institutions
- Others : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2017 | Others | ₹7.50 M | Satisfied |
How Many Employees Work at Shef Biotech?
Unlock and access historical data on people associated with Shef Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shef Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shef Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.